Table 3. TGF-β, IL-6, IL-10, IL-23 and IL-17 in patients with VKH disease.

Characteristics	Active VKH patients	Inactive VKH patients	Healthy controls	aP	bP	cP
IL-17	12.68±3.43	10.31±2.00	9.55±1.02	0.01	0.34	0.03
IL-23	11.67±9.52	7.84±2.58	6.71±0.76	0.06	0.26	0.04
IL-6	5.16±5.00	4.03±8.40	3.99±0.34	0.02	0.05	0.04
TGF-β	3890.14±2529.36	1825.46±1316.31	1721.94±1269.82	0.03	0.06	0.01
IL-10	7.00±6.85	21.96±7.65	22.04±7.36	0.04	0.08	0.01

VKH: Vogt-Koyanagi-Harada. ^aHealthy controls vs active patients; ^bHealthy controls vs inactive patients; ^cActive patients vs inactive patients.

mean±SD, pg/mL